Morpholine-based substance P antagonists: assessment of the 3-point binding model
- 25 August 1994
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 4 (16) , 1917-1920
- https://doi.org/10.1016/s0960-894x(01)80534-5
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Quinuclidine based NK-1 antagonists 2: determination of the absolute stereochemical requirementsBioorganic & Medicinal Chemistry Letters, 1993
- N-Acyl-L-tryptophan benzyl esters: potent substance P receptor antagonistsJournal of Medicinal Chemistry, 1993
- Quinuclidine-based NK-1 antagonists I: 3-benzyloxy-1-azabicyclo[2.2.2]octanesBioorganic & Medicinal Chemistry Letters, 1993
- Discovery of a potent substance P antagonist: recognition of the key molecular determinantJournal of Medicinal Chemistry, 1992
- The discovery of (2S,3S)-cis-2-(diphenylmethyl)-N-[(2-methoxyphenyl)methyl]-1-azabicyclo[2.2.2]octan-3-amine as a novel, nonpeptide substance P antagonistJournal of Medicinal Chemistry, 1992
- Neurogenic versus vascular mechanisms of sumatriptan and ergot alkaloids in migraineTrends in Pharmacological Sciences, 1992
- Pharmacological properties of a potent and selective nonpeptide substance P antagonist.Proceedings of the National Academy of Sciences, 1991
- Substance P Activation of Rheumatoid Synoviocytes: Neural Pathway in Pathogenesis of ArthritisScience, 1987
- Synthesis and reduction of α-amino ketones derived from leucineJournal of the Chemical Society, Perkin Transactions 1, 1986
- cis- and trans-3-Methyl-2-phenylmorpholineThe Journal of Organic Chemistry, 1962